BioArctic AB Forecast, price target & analysts
BioArctic AB Target price 2025 - Analyst rating & recommendation
BioArctic AB Classifications & Recommendation:
BioArctic AB Price Target
| Target Price | kr285.60 |
| Price | kr313.40 |
| Deviation |
8.87%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target BioArctic AB 2026 .
The average BioArctic AB target price is kr285.60.
This is
8.87%
register free of charge
kr370.65
18.27%
register free of charge
kr222.20
29.10%
register free of charge
|
|
| A rating was issued by 9 analysts: 7 Analysts recommend BioArctic AB to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioArctic AB stock has an average upside potential 2026 of
8.87%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion kr | 0.26 | 2.07 |
| 58.22% | 703.57% | |
| EBITDA Margin | -82.15% | 58.66% |
| 278.81% | 171.40% | |
| Net Margin | -68.81% | 49.98% |
| 284.89% | 172.64% |
6 Analysts have issued a sales forecast BioArctic AB 2025 . The average BioArctic AB sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an BioArctic AB EBITDA forecast 2025. The average BioArctic AB EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 BioArctic AB Analysts have issued a net profit forecast 2025. The average BioArctic AB net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share kr | -2.00 | 11.68 |
| 177.22% | 684.00% | |
| P/E | 26.84 | |
| EV/Sales | 12.31 |
5 Analysts have issued a BioArctic AB forecast for earnings per share. The average BioArctic AB EPS is
This results in the following potential growth metrics and future valuations:
Current BioArctic AB Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Sep 01 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | May 21 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | May 20 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| RX SECURITIES |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Feb 16 2025 |
| DNB MARKETS |
Locked
➜
Locked
|
Locked | Feb 16 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Sep 01 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
May 21 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
May 20 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
RX SECURITIES:
Locked
➜
Locked
|
Mar 24 2025 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Feb 16 2025 |
|
Locked
DNB MARKETS:
Locked
➜
Locked
|
Feb 16 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
